Drug recall · November 13, 2019
Sankaijo BOTANICAL LAXATIVE recall
Why: Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
- Lots / codes
Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21
- Quantity
- 17,284 bottles
- Company
- Sato Pharmaceutical Inc., Torrance, CA
- Distribution
- Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
- Initiated
- October 1, 2019 · Voluntary: Firm initiated
- Classified
- November 7, 2019
- Reported
- November 13, 2019
- Ended
- August 18, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Docusate / sennosides, USP
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.